计算溶液所需的质量、体积或浓度。
活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
---|
货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
---|---|---|---|---|
C153471-1g |
1g |
现货 ![]() |
| |
C153471-5g |
5g |
现货 ![]() |
| |
C153471-25g |
25g |
现货 ![]() |
| |
C153471-100g |
100g |
现货 ![]() |
|
别名 | 2-十六烷氧基-6-甲基-4H-3,1-苯并恶嗪-4-酮 | 西替利斯他 | 赛利司他 | 西替利斯塔 |
---|---|
英文别名 | SCHEMBL367612 | AMY25231 | Betahistine mesilate (JP17) | Cetilistat [INN] | F16711 | ATL962 | ATL-962 | Cametor | CETILISTAT [JAN] | MK-212-HCL | N-(dicyclopropylmethyl)-4,5-dihydrooxazol-2-amine; phosphoric acid | UNII-LC5G1JUA39 | AKOS025248278 | CCG-26 |
规格或纯度 | Moligand™, ≥98%(HPLC) |
英文名称 | Cetilistat |
运输条件 | 常规运输 |
作用类型 | 抑制剂 |
作用机制 | 胃脂肪酶抑制剂 |
产品介绍 |
Cetilistat (ATL-962) 是一种胰腺脂肪酶 (pancreatic lipase) 抑制剂,可作为有效的抗肥胖药。Cetilistat 抑制大鼠和人胰脂肪酶活性,IC50 分别为 54.8 nM 和 5.95 nM。 Product Describtion: Cetilistat (ATL-962), an inhibitor of pancreatic lipase, acts as an effective anti-obesity agent. Cetilistat inhibits rat and human pancreatic lipase activity with IC50s of 54.8 nM, and 5.95 nM, respectively. |
ALogP | 9.8 |
---|
作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
---|
PubChem SID | 488196466 |
---|---|
分子类型 | 小分子 |
IUPAC Name | 2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one |
INCHI | InChI=1S/C25H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-19-28-25-26-23-18-17-21(2)20-22(23)24(27)29-25/h17-18,20H,3-16,19H2,1-2H3 |
InChi Key | MVCQKIKWYUURMU-UHFFFAOYSA-N |
Canonical SMILES | CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C=C2)C)C(=O)O1 |
Isomeric SMILES | CCCCCCCCCCCCCCCCOC1=NC2=C(C=C(C=C2)C)C(=O)O1 |
PubChem CID | 9952916 |
分子量 | 401.59 |
Reaxy-Rn | 14110675 |
溶解性 | Insoluble in DMSO; ≥4.12 mg/mL in EtOH (Need ultrasonic and warming); insoluble in H2O |
---|---|
熔点 | 72.0 ~76.0 °C |
分子量 | 401.600 g/mol |
XLogP3 | 9.800 |
氢键供体数Hydrogen Bond Donor Count | 0 |
氢键受体数Hydrogen Bond Acceptor Count | 4 |
可旋转键计数Rotatable Bond Count | 16 |
精确质量Exact Mass | 401.293 Da |
单同位素质量Monoisotopic Mass | 401.293 Da |
拓扑极表面积Topological Polar Surface Area | 47.900 Ų |
重原子数Heavy Atom Count | 29 |
形式电荷Formal Charge | 0 |
复杂度Complexity | 477.000 |
同位素原子数Isotope Atom Count | 0 |
定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
所有立体化学键的总数The total count of all stereochemical bonds | 0 |
共价键合单元计数Covalently-Bonded Unit Count | 1 |
Reaxy-Rn | 14110675 |
---|
Purity(HPLC) | 98-100(%) |
---|---|
Melting point | 72-76(℃) |
Appearance(C153471) | White to Off-White Solid, Powder, or Crystals |
Proton NMR spectrum | Conforms to Structure |
1. Jinpeng Liu, Mashooq Khan, Yong Wei, Anna Liu, Tao Wang, Qiongzheng Hu, Li Yu. (2023) High-throughput screening of lipase inhibitors as anti-obesity drugs on liquid crystal-infused porous surfaces. SENSORS AND ACTUATORS B-CHEMICAL, 387 (133837). [10.1016/j.snb.2023.133837] |
2. Wenzhe Ji, Dingqiang Lu, Shaoning Yang, Tongqi Liu, Xinxian Wang, Xiuquan Ling. (2016) Solubility and solution thermodynamics of cetilistat in water and (acetone, isopropyl alcohol, acetonitrile) binary solvent mixtures. JOURNAL OF MOLECULAR LIQUIDS, 224 (1380). [10.1016/j.molliq.2016.10.127] |
1. Kopelman P, Bryson A, Hickling R, Rissanen A, Rossner S, Toubro S, Valensi P. (2007) Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.. Int J Obes (Lond.), 31 (3): (494-9). [PMID:16953261] [10.1021/op500134e] |
2. Gras J. (2013) Cetilistat for the treatment of obesity.. Drugs Today (Barc), 49 (12): (755-9). [PMID:24524093] [10.1021/op500134e] |
3. Yuan S, Chan JFW, Chik KKH, Chan CCY, Tsang JOL, Liang R, Cao J, Tang K, Chen LL, Wen K et al.. (2020) Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.. Pharmacol Res, 159 (13): (104960). [PMID:32473310] [10.1021/op500134e] |
4. Jinpeng Liu, Mashooq Khan, Yong Wei, Anna Liu, Tao Wang, Qiongzheng Hu, Li Yu. (2023) High-throughput screening of lipase inhibitors as anti-obesity drugs on liquid crystal-infused porous surfaces. SENSORS AND ACTUATORS B-CHEMICAL, 387 (133837). [10.1016/j.snb.2023.133837] |
5. Wenzhe Ji, Dingqiang Lu, Shaoning Yang, Tongqi Liu, Xinxian Wang, Xiuquan Ling. (2016) Solubility and solution thermodynamics of cetilistat in water and (acetone, isopropyl alcohol, acetonitrile) binary solvent mixtures. JOURNAL OF MOLECULAR LIQUIDS, 224 (1380). [10.1016/j.molliq.2016.10.127] |